Kimberly Manhard
Overview
Kimberly Manhard received an average of $2M in total compensation, including $498K in salary, at Heron Therapeutics from 2017 to 2022.
2022Heron TherapeuticsExecutive Vice President, Drug Development
2021Heron TherapeuticsExecutive Vice President, Drug Development
2020Heron TherapeuticsExecutive Vice President, Drug Development
2019Heron TherapeuticsExecutive Vice President, Drug Development
2018Heron TherapeuticsExecutive Vice President, Drug Development
2017Heron TherapeuticsExecutive Vice President, Drug Development
Source: SEC filings on May 1, 2023, April 25, 2022, April 22, 2021, and April 23, 2020.
Related executives
We found 22 more executives who work or worked at Heron Therapeutics.
Craig Collard
Heron Therapeutics
Chief Executive Officer
Barry Quart
Heron Therapeutics
Chief Executive Officer
David Szekeres
Heron Therapeutics
Executive Vice President, Chief Commercial Officer
Ira Duarte
Heron Therapeutics
Chief Financial Officer
William Forbes
Heron Therapeutics
Chief Development Officer
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
Robert Hoffman
Heron Therapeutics
Chief Financial Officer
News
Heron Therapeutics Executive Vice President, Drug Development Kimberly Manhard's 2022 pay falls 22% to $1.4M
May 1, 2023
Heron Therapeutics CEO Barry Quart's 2021 pay rises 2% to $5.4M
April 25, 2022
Heron Therapeutics CEO Barry Quart's 2020 pay slips 9% to $5.3M
April 22, 2021
Heron Therapeutics CEO Barry Quart's 2019 pay slips 2% to $5.9M
April 23, 2020